Wanbury

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE107F01022
  • NSEID: WANBURY
  • BSEID: 524212
INR
257.80
5.8 (2.3%)
BSENSE

May 06

BSE+NSE Vol: 37.24 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Wanbury
Lincoln Pharma.
Ind-Swift Labs.
Anuh Pharma
Bajaj Healthcare
Kopran
Bharat Parenter.
Themis Medicare
Fermenta Biotec.
Accent Microcell
Remus Pharma.

Why is Wanbury Ltd ?

1
High Debt Company with a Debt to Equity ratio (avg) of 3.36 times
  • Poor long term growth as Net Sales has grown by an annual rate of 14.16% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) of 3.36 times
2
Healthy long term growth as Operating profit has grown by an annual rate 107.56%
3
The company has declared Positive results for the last 3 consecutive quarters
  • PAT(Latest six months) At Rs 30.94 cr has Grown at 234.85%
  • OPERATING PROFIT TO INTEREST(Q) Highest at 3.68 times
  • DEBT-EQUITY RATIO(HY) Lowest at 1.83 times
4
With ROCE of 33.3, it has a Attractive valuation with a 4.8 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 11.19%, its profits have risen by 252.3% ; the PEG ratio of the company is 0.1
5
86.69% of Promoter Shares are Pledged
  • In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Wanbury should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Wanbury for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Wanbury
11.19%
0.22
51.50%
Sensex
-3.33%
-0.25
13.43%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
14.16%
EBIT Growth (5y)
107.56%
EBIT to Interest (avg)
1.29
Debt to EBITDA (avg)
2.18
Net Debt to Equity (avg)
2.77
Sales to Capital Employed (avg)
3.19
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
86.69%
Institutional Holding
0.59%
ROCE (avg)
31.95%
ROE (avg)
42.23%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
21
Industry P/E
34
Price to Book Value
15.18
EV to EBIT
14.31
EV to EBITDA
12.09
EV to Capital Employed
4.76
EV to Sales
1.69
PEG Ratio
0.09
Dividend Yield
NA
ROCE (Latest)
33.30%
ROE (Latest)
72.53%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
PAT(Latest six months)

At Rs 30.94 cr has Grown at 234.85%

OPERATING PROFIT TO INTEREST(Q)

Highest at 3.68 times

DEBT-EQUITY RATIO(HY)

Lowest at 1.83 times

-4What is not working for the Company
ROCE(HY)

Lowest at 27.36%

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.94 times

Loading Valuation Snapshot...

Here's what is working for Wanbury

Profit After Tax (PAT) - Latest six months
At Rs 30.94 cr has Grown at 234.85%
Year on Year (YoY)
MOJO Watch
PAT trend is very positive

PAT (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 3.68 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Debt-Equity Ratio - Half Yearly
Lowest at 1.83 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Wanbury

Debtors Turnover Ratio- Half Yearly
Lowest at 4.94 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio